98 related articles for article (PubMed ID: 31782000)
1. Marker Systems Based on MicroRNA Gene Methylation for the Diagnosis of Stage I-II Breast Cancer.
Braga EA; Filippova EA; Loginov VI; Pronina IV; Burdennyi AM; Kazubskaya TP; Fridman MV; Khodyrev DS; Kushlinskii NE
Bull Exp Biol Med; 2019 Dec; 168(2):280-284. PubMed ID: 31782000
[TBL] [Abstract][Full Text] [Related]
2. [A Group of Hypermethylated miRNA Genes in Breast Cancer and Their Diagnostic Potential].
Filippova EA; Loginov VI; Pronina IV; Khodyrev DS; Burdennyya AM; Kazubskaya TP; Braga EA
Mol Biol (Mosk); 2019; 53(3):421-429. PubMed ID: 31184607
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems.
Filippova EA; Loginov VI; Burdennyi AM; Braga EA; Pronina IV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Fridman MV; Khodyrev DS; Kushlinskii NE
Bull Exp Biol Med; 2019 May; 167(1):79-83. PubMed ID: 31177462
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma.
Braga EA; Loginov VI; Filippova EA; Burdennyi AM; Pronina IV; Kazubskaya TP; Khodyrev DS; Utkin DO; Kushlinskii DN; Adamyan LV; Kuslinskii NE
Bull Exp Biol Med; 2018 Dec; 166(2):253-256. PubMed ID: 30488208
[TBL] [Abstract][Full Text] [Related]
6. Optimized Marker System for Early Diagnosis of Breast Cancer.
Burdennyy AM; Filippova EA; Khodyrev DS; Pronina IV; Lukina SS; Ivanova NA; Kazubskaya TP; Loginov VI; Braga EA
Bull Exp Biol Med; 2021 Nov; 172(1):57-62. PubMed ID: 34791555
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Methylation of 21 MicroRNA Genes in Breast Cancer: Sets of Genes Associated with Progression and a System of Markers for Predicting Metastasis.
Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Karpukhin AV; Khodyrev DS; Braga EA
Bull Exp Biol Med; 2021 Nov; 172(1):67-71. PubMed ID: 34792716
[TBL] [Abstract][Full Text] [Related]
8. [The hyper-methylated genes microRNA as potential markers of clear-cell carcinoma of kidney].
Beresneva EV; Loginov VI; Khodyrev DS; Pronina IV; Kazubskaya TP; Karpukhin AV; Braga EA; Kushlinskii NE
Klin Lab Diagn; 2017 Jan; 62(1):13-8. PubMed ID: 30615358
[TBL] [Abstract][Full Text] [Related]
9. System of Markers Based on the Methylation of a Group of Proapoptotic Genes in Combination with MicroRNA in the Diagnosis of Breast Cancer.
Braga EA; Burdennyy AM; Pronina IV; Filippova EA; Kazubskaya TP; Fridman MV; Khodyrev DS; Karpukhin AV; Loginov VI; Kushlinskii NE
Bull Exp Biol Med; 2020 Jan; 168(3):366-370. PubMed ID: 31938917
[TBL] [Abstract][Full Text] [Related]
10. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
Sandhu R; Rivenbark AG; Mackler RM; Livasy CA; Coleman WB
Int J Oncol; 2014 Feb; 44(2):563-72. PubMed ID: 24297604
[TBL] [Abstract][Full Text] [Related]
12. Relationship of the Levels of microRNA Gene Methylation with the Level of Their Expression and Pathomorphological Characteristics of Breast Cancer.
Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Braga EA; Burdennyi AM; Loginov VI
Bull Exp Biol Med; 2021 Oct; 171(6):764-769. PubMed ID: 34705180
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
[TBL] [Abstract][Full Text] [Related]
14. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
15. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
16. MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.
Torres-Ferreira J; Ramalho-Carvalho J; Gomez A; Menezes FD; Freitas R; Oliveira J; Antunes L; Bento MJ; Esteller M; Henrique R; Jerónimo C
Mol Cancer; 2017 Jan; 16(1):26. PubMed ID: 28143614
[TBL] [Abstract][Full Text] [Related]
17. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY
Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357
[TBL] [Abstract][Full Text] [Related]
18. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
[TBL] [Abstract][Full Text] [Related]
19. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654
[TBL] [Abstract][Full Text] [Related]
20. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
